- Home
- ISPO vs ANVS Comparison
ISPO vs ANVS Comparison
Compare ISPO & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ISPO
- ANVS
- Stock Information
- Founded
- ISPO 2010
- ANVS 2008
- Country
- ISPO United States
- ANVS United States
- Employees
- ISPO N/A
- ANVS N/A
- Industry
- ISPO Blank Checks
- ANVS Biotechnology: Pharmaceutical Preparations
- Sector
- ISPO Finance
- ANVS Health Care
- Exchange
- ISPO Nasdaq
- ANVS Nasdaq
- Market Cap
- ISPO 44.3M
- ANVS 44.6M
- IPO Year
- ISPO N/A
- ANVS 2020
- Fundamental
- Price
- ISPO $3.66
- ANVS $2.71
- Analyst Decision
- ISPO
- ANVS Strong Buy
- Analyst Count
- ISPO 0
- ANVS 4
- Target Price
- ISPO N/A
- ANVS $18.00
- AVG Volume (30 Days)
- ISPO 35.8K
- ANVS 454.6K
- Earning Date
- ISPO 08-12-2025
- ANVS 08-14-2025
- Dividend Yield
- ISPO N/A
- ANVS N/A
- EPS Growth
- ISPO N/A
- ANVS N/A
- EPS
- ISPO N/A
- ANVS N/A
- Revenue
- ISPO $265,499,000.00
- ANVS N/A
- Revenue This Year
- ISPO N/A
- ANVS N/A
- Revenue Next Year
- ISPO $148.67
- ANVS N/A
- P/E Ratio
- ISPO N/A
- ANVS N/A
- Revenue Growth
- ISPO N/A
- ANVS N/A
- 52 Week Low
- ISPO $3.11
- ANVS $1.11
- 52 Week High
- ISPO $9.31
- ANVS $17.88
- Technical
- Relative Strength Index (RSI)
- ISPO 49.55
- ANVS 55.27
- Support Level
- ISPO $3.45
- ANVS $2.24
- Resistance Level
- ISPO $3.87
- ANVS $2.79
- Average True Range (ATR)
- ISPO 0.40
- ANVS 0.26
- MACD
- ISPO -0.03
- ANVS -0.02
- Stochastic Oscillator
- ISPO 25.32
- ANVS 52.65
About ISPO Inspirato Incorporated
Inspirato Inc is a private, luxury hospitality club that provides its members with access to an exclusive portfolio of high-end vacation homes, luxury hotels, and curated travel experiences worldwide. The club offers personalized service, dedicated trip planning, and seamless access to exceptional properties through its innovative model designed to ensure the service, certainty and value that discerning customers demand. The Inspirato portfolio of curated luxury vacation options includes approximately 350 private luxury vacation homes and accommodations at over 220 luxury hotel and resort partners in over 180 destinations around the world.
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.